Literature DB >> 15907811

Pharmacological characterization of antiepileptic drugs and experimental analgesics on low magnesium-induced hyperexcitability in rat hippocampal slices.

Robert L Arias1, Mark R Bowlby.   

Abstract

Perfusion of acute hippocampal slices with stimulatory buffers has long been known to induce rhythmic, large amplitude, synchronized spontaneous neuronal bursting in areas CA1 and CA3. The characteristics of this model of neuronal hyperexcitability were investigated in this study, particularly with respect to the activity of antiepileptic drugs and compounds representing novel mechanisms of analgesic action. Toward that end, low Mg(2+)/high K(+)-induced spontaneous activity was quantified by a virtual instrument designed for the digitization and analysis of bursting activity. Uninterrupted streams of extracellular field potentials were digitized and analyzed in 10-s sweeps, yielding four quantified parameters of neuronal hyperexcitability. Following characterization of the temporal stability of low Mg(2+)/high K(+)-induced hyperexcitability, compounds representing a diversity of functional mechanisms were tested for their effectiveness in reversing this activity. Of the four antiepileptic drugs tested in this model, only phenytoin proved ineffective, while valproate, gabapentin and carbamazepine varied in their potencies, with only the latter drug proving to be completely efficacious. In addition, three investigational compounds having analgesic potential were examined: ZD-7288, a blocker of HCN channels; EAA-090, an NMDA antagonist; and WAY-132983, a muscarinic agonist. Each of these compounds showed strong efficacy by completely blocking spontaneous bursting activity, along with potency greater than that of the antiepileptic drugs. These data indicate that pharmacological agents with varying mechanisms of action are able to block low Mg(2+)/high K(+)-induced hyperexcitability, and thus this model may represent a useful tool for identifying novel agents and mechanisms involved in epilepsy and neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907811     DOI: 10.1016/j.brainres.2005.04.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Cerebellar syndrome in chronic cyclic magnesium depletion.

Authors:  Luis Miguel Blasco
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity.

Authors:  Alison O'Mahony; Jacob Raber; Mauricio Montano; Erik Foehr; Victor Han; Shao-ming Lu; Hakju Kwon; Anthony LeFevour; Shikha Chakraborty-Sett; Warner C Greene
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

4.  The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review.

Authors:  Miriam Kessi; Jing Peng; Haolin Duan; Hailan He; Baiyu Chen; Juan Xiong; Ying Wang; Lifen Yang; Guoli Wang; Karlmax Kiprotich; Olumuyiwa A Bamgbade; Fang He; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-05-19       Impact factor: 6.261

5.  Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics.

Authors:  Seongeun Cho; Andrew Wood; Mark R Bowlby
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

6.  New in vitro phenotypic assay for epilepsy: fluorescent measurement of synchronized neuronal calcium oscillations.

Authors:  Nathalie Pacico; Ana Mingorance-Le Meur
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.